Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC FTISADTSK acetate | 99.7% | 1029.10 | 5 MG
Supplier: Medchemexpress LLC HYP3146A5MG
FTISADTSK acetate is an endogenous stable signature peptide derived from Trastuzumab. It is specifically monitored by selected reaction monitoring (SRM) and is intended solely for research applications.
- Endogenous stable signature peptide
- Monitored by selected reaction monitoring (SRM)
- Suitable for research use only
- Solid appearance, ranging from white to light brown
- Molecular weight: 1029.10
- Chemical formula: C44H72N10O18
- Soluble in water at 50 mg/mL (48.59 mM), may require sonication
- Powder storage: -80°C for 2 years or -20°C for 1 year
- Solution storage: -80°C for 6 months or -20°C for 1 month (sealed, away from moisture)
- Ships at room temperature within the continental US
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?